Items where Author is "Kanz, L."

Article

Knop, Stefan and Engelhardt, Monika and Liebisch, Peter and Meisner, Christoph and Holler, Ernst and Metzner, Bernd and Peest, Dietrich and Kaufmann, Martin and Bunjes, Donald and Straka, Christian and Fischer, Thomas and Sezer, Orhan and Hentrich, Marcus and Ostermann, Helmut and Bassermann, Florian and Hess, Georg and Hertenstein, Bernd and Freund, Mathias and Kropff, Martin and Schmidt, Christian A. and Wolf, Hans-Heinrich and Jung, Wolfram and Frickhofen, Norbert and Mielke, Stephan and Bargou, Ralf C. and Maschmeyer, Georg and Svaldi, Mirija and Langer, Christian H. and Gramatzki, Martin and Hebart, Holger and Kanz, Lothar and Einsele, Hermann and Sezer, O. and Doerken, B. and Gerecke, C. and Fuhrmann, S. and Ludwig, W. D. and Hertenstein, B. and Bormann, M. and Meyer, R. and Naumann, R. and Platzbecker, U. and Roellig, Ch and Roesler, W. and von Metzler, I and Martin, H. and Engelhardt, M. and Finke, J. and Truemper, L. and Jung, W. and Schmidt, Ch A. and Doelken, G. and Wolf, H. H. and Mueller, L. and Ligeti, K. and Kroeger, N. and Schilling, G. and Duerk, H. and Peest, D. and Ganser, A. and Pfreundschuh, M. and Sayer, H. and von Lilienfeld-Toal, M. and Muegge, L. O. and Bentz, M. and Gramatzki, M. and Brueggemann, M. and Fischer, T. and Wolleschak, D. and Hess, G. and Kropff, M. and Reusch, J. and Straka, C. and Ostermann, H. and Franke, D. and Peschel, C. and Dechow, T. and Bassermann, F. and Hentrich, M. and Wandt, H. and Schaefer-Eckart, K. and Metzner, B. and Maschmeyer, G. and Holler, E. and Hart, C. and Reichle, A. and Freund, M. and Boettcher, S. and Kahl, C. and Mergenthaler, H. G. and Aulitzky, W. and Kaufmann, M. and Greiner, J. and Heidemann, E. and Kanz, L. and Hebart, H. and Liebisch, P. and Bunjes, D. and Langer, C. and Frickhofen, N. and Einsele, H. and Knop, S. and Mielke, S. and Bargou, R. C. and Svaldi, M. (2019) Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis. LEUKEMIA, 33 (11). pp. 2710-2719. ISSN 0887-6924, 1476-5551

Hehlmann, R. and Lauseker, M. and Saussele, S. and Pfirrmann, M. and Krause, S. and Kolb, H. J. and Neubauer, A. and Hossfeld, D. K. and Nerl, C. and Gratwohl, A. and Baerlocher, G. M. and Heim, D. and Bruemmendorf, T. H. and Fabarius, A. and Haferlach, C. and Schlegelberger, B. and Mueller, M. C. and Jeromin, S. and Proetel, U. and Kohlbrenner, K. and Voskanyan, A. and Rinaldetti, S. and Seifarth, W. and Spiess, B. and Balleisen, L. and Goebeler, M. C. and Haenel, M. and Ho, A. and Dengler, J. and Falge, C. and Kanz, L. and Kremers, S. and Burchert, A. and Kneba, M. and Stegelmann, F. and Koehne, C. A. and Lindemann, H. W. and Waller, C. F. and Pfreundschuh, M. and Spiekermann, K. and Berdel, W. E. and Mueller, L. and Edinger, M. and Mayer, J. and Beelen, D. W. and Bentz, M. and Link, H. and Hertenstein, B. and Fuchs, R. and Wernli, M. and Schlegel, F. and Schlag, R. and de Wit, M. and Truemper, L. and Hebart, H. and Hahn, M. and Thomalla, J. and Scheid, C. and Schafhausen, P. and Verbeek, W. and Eckart, M. J. and Gassmann, W. and Pezzutto, A. and Schenk, M. and Brossart, P. and Geer, T. and Bildat, S. and Schaefer, E. and Hochhaus, A. and Hasford, J. (2017) Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants. LEUKEMIA, 31 (11). pp. 2398-2406. ISSN 0887-6924, 1476-5551

Vrhovac, R. and Labopin, M. and Ciceri, F. and Finke, J. and Holler, E. and Tischer, J. and Lioure, B. and Gribben, J. and Kanz, L. and Blaise, D. and Dreger, P. and Held, G. and Arnold, R. and Nagler, A. and Mohty, M. (2016) Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. BONE MARROW TRANSPLANTATION, 51 (2). pp. 186-193. ISSN 0268-3369, 1476-5365

Knop, S. and Liebisch, P. and Hebart, H. and Holler, E. and Engelhardt, M. and Bargou, R. C. and Metzner, B. and Doelken, G. and Peest, D. and Aulitzky, W. and Bunjes, D. and Straka, C. and Wandt, H. and Sezer, O. and Hentrich, M. and Ostermann, H. and Dechow, T. and Hess, G. and Hertenstein, B. and Freund, M. and Kropff, M. and Wolf, H. and Jung, W. and Frickhofen, N. and Maschmeyer, G. and Mergenthaler, H. and Kanz, L. and Meisner, C. and Einsele, H. (2011) Up front allogeneic stem cell transplant is superior to tandem high-dose melphalan in cytogenetically defined ultra high-risk myeloma. ONKOLOGIE, 34 (Suppl6). pp. 199-200. ISSN 0378-584X

Schmidt-Hieber, M. and Blau, I. W. and Trenschel, R. and Andreesen, R. and Stuhler, G. and Einsele, H. and Kanz, L. and Keilholz, U. and Marinets, O. and Beelen, D. W. and Fauser, A. A. and Volin, L. and Ruutu, T. and Uharek, L. and Fietz, T. and Knauf, W. and Hopfenmueller, W. and Thiel, E. and Freund, M. and Casper, J. (2007) Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. BONE MARROW TRANSPLANTATION, 39 (7). pp. 389-396. ISSN 0268-3369

Schmidt-Hieber, M. and Casper, J. and Trenschel, R. and Andreesen, R. and Einsele, H. and Kanz, L. and Fauser, A. and Uharek, L. and Thiel, E. and Blau, I. (2006) Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients. BONE MARROW TRANSPLANTATION, 37 (Suppl1). S195-S196. ISSN 0268-3369

Schmoll, Hans-Joachim and Kollmannsberger, C. and Metzner, B. and Hartmann, J. T. and Schleucher, N. and Schoeffski, P. and Schleicher, J. and Rick, O. and Beyer, J. and Hossfeld, D. and Kanz, L. and Berdel, W. E. and Andreesen, Reinhard and Bokemeyer, C. (2003) Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: An extended phase I/II study of the German testicular cancer study group. JOURNAL OF CLINICAL ONCOLOGY, 21 (22). pp. 4083-4091. ISSN 0732-183X

Other

Pfreundschuh, M. and Christofyllakis, K. and Altmann, B. and Ziepert, M. and Haenel, M. and Viardot, A. and Neubauer, A. and Held, G. and Truemper, L. and Schmidt, C. and Kanz, L. and Hallek, M. and Schmitz, N. and Heintges, T. and Koelbel, C. and Schneider, G. and Ruebe, C. and Hellwig, D. and Poeschel, V. and Murawski, N. (2017) Radiotherapy to bulky disease PET-negative after immunochemotherapy can be spared in elderly DLBCL patients: results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL > 60 study of the DSHNHL. KARGER, BASEL.

Schreder, M. and Liebisch, P. and Hebart, H. and Holler, E. and Engelhardt, M. and Metzner, B. and Peest, D. and Aulitzky, W. and Straka, C. and Fischer, T. and Sezer, O. and Hentrich, M. and Ostermann, H. and Peschel, C. and Hess, G. and Hertenstein, B. and Wolf, H. -H and Jung, W. and Frickhofen, N. and Maschmeyer, G. and Langer, C. and Meisner, C. and Kanz, L. and Einsele, H. and Knop, S. (2016) Randomized comparison of pegylated IFN-a2b versus IFN-a2b maintenance following tandem autologous transplant in multiple myeloma. KARGER, BASEL.

Vrhovac, R. and Labopin, M. and Ciceri, F. and Finke, J. and Holler, E. and Tischer, J. and Lioure, B. and Gribben, J. and Kanz, L. and Blaise, D. and Dreger, P. and Nagler, A. and Held, G. and Arnold, R. and Mohty, M. (2014) SECOND RIC ALLOGENEIC TRANSPLANT AS A RESCUE STRATEGY FOR ACUTE LEUKAEMIA PATIENTS WHO RELAPSE AFTER AN INITIAL RIC ALLOGENEIC TRANSPLANTATION: ANALYSIS OF RISK FACTORS AND TREATMENT OUTCOMES. NATURE PUBLISHING GROUP, LONDON.